Clinical Trials- Esophageal

 TITLE  Phase  CONTACT  LOCATION
 A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma (RTOG 1010)  III Gladys Pierce RN
gladys.pierce@nmhs.org
402-354-5129
 Nebraska Methodist Hospital
Omaha
 Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer  (CALGB-80803)  II  Gladys Pierce RN
gladys.pierce@nmhs.org
402-354-5129
 Nebraska Methodist Hospital
Omaha
 A Phase II Study of Neo-Adjuvant Therapy with Oxaliplatin, Leucovorin, 5-Flouracil, Panitumumab (Vectibix) and Radiation in Patients with  Locally Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction (NCT01307956)  II

Deborah Meyer, RN, BGS

Associate Research Subject Advocate

University of Nebraska Medical Center

Center for Clinical and Translational Research

(402) 559-6941

 Nebraska Medical Center, Omaha NE
 A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer  (SWOG 1201)  II  Good Samaritan – Michaela Sherbeck - michaelasherbeck@catholichealth.net

 

 Good Samaritan Cancer Center, Kearney, NE

 

 

 

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software